China Urges APEC Cooperation as Commerce Minister Skips Meeting Over Urgent Official Business JM Smucker SJM Faces Lower Forward Estimates After JPMorgan Price Target Cut Dover Border Check Suspension May Pressure Ferry Operators Amid Travel Delays Wingstop Shares Decline After Earnings Miss Market Expectations Republican Attorneys General Break Ranks with House Colleagues on Social Media Legislation Trump Administration Maintains Iran Naval Blockade Until Agreement Reached President Dismisses Critics Box Q1 2026 Earnings Strong EPS Beat Drives Positive Momentum Keysight Technologies Q1 2026 Earnings Strong EPS Beat of 212 Amid Revenue Uncertainty Ziff Davis Inc Q1 2026 Earnings EPS Misses Expectations Despite Positive Stock Reaction Norwegian Cruise Line NCLH Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction Liberty Latin America Ltd LILAK Q1 2026 Earnings EPS Misses Estimates Sharply Despite Strong Stock Rally Sharps Technology Inc STSS Q3 2025 Earnings EPS Misses Wide as PreRevenue Focus Intensifies Launch Two Acquisition Corp LPBB Holds Steady at 1067 as SPAC Trading Remains Rangebound Rallybio Corporation RLYB Faces Headwinds Stock Slides 236 as Key Support Levels Tested Danaher DHR Slips Slightly Amid Broader Market Caution Key Support and Resistance Levels in Focus Virco Manufacturing VIRC Dips 197 Tests Key Support Near 568 JF Stock Declines 297 as Selling Pressure Tests Key Support Near 093 European Gas Storage Levels Face Pressure from Continued Hormuz Disruption Risks GSBC Q1 2026 Earnings Strong EPS Beat Despite Slight Stock Decline Amprius Technologies AMPX Sheds 376 as Shares Test Key Support Levels Electrovaya Inc Q1 2026 Earnings EPS Beats Estimates by 307 Stock Gains 207 ABNB Q1 2026 Earnings EPS Misses Estimates Amid Mixed Performance ZURA Q1 2026 Earnings PreRevenue Biotech Reports WiderThanExpected Loss CalMaine Foods Inc CALM Q1 2026 Earnings Egg Producer Beats Estimates as Margin Recovery Lifts Bottom Line HCI Q1 2026 Earnings EPS Surpasses Estimates by 475 YSG Q4 2025 Earnings Positive EPS but Revenue Transparency Remains Limited SRPT Q1 2026 Earnings EPS Smashes Estimates by 1847 as Gene Therapy Execution Drives Profit Surprise